Tamil Nadu, India

Sundaraselvan Ariyamuthu

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Teva Pharmaceuticals International Gmbh. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sundaraselvan Ariyamuthu. Retrieved from https://idiyas.com/inventor/sundaraselvan-ariyamuthu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Sundaraselvan Ariyamuthu

Introduction

Sundaraselvan Ariyamuthu is a notable inventor based in Tamil Nadu, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for the preparation of important medicinal compounds.

Latest Patents

Ariyamuthu holds a patent for "Processes for the preparation of sofosbuvir and intermediates thereof." This patent outlines procedures and intermediates for the preparation of Sofosbuvir, which includes the step of reacting a compound of a specific formula. The innovation is crucial for the synthesis of this antiviral medication, which is used in the treatment of hepatitis C.

Career Highlights

Ariyamuthu is currently employed at Teva Pharmaceuticals International GmbH, a leading global pharmaceutical company. His work focuses on developing efficient methods for drug synthesis, contributing to the advancement of pharmaceutical sciences.

Collaborations

Some of his notable coworkers include Vinod Kumar Kansal and Dhirenkumar Natvarial Mistry, who collaborate with him on various projects within the pharmaceutical sector.

Conclusion

Sundaraselvan Ariyamuthu's innovative work in the preparation of sofosbuvir highlights his valuable contributions to the pharmaceutical industry. His expertise and collaborations continue to drive advancements in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…